Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) Property, Plant and Equipment: ¥523 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688266 Suzhou Zelgen Biopharmaceuticals Co Ltd SHSE:688266
70 GF Score
Price ¥112.22
GF Value ¥221.15
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Suzhou Zelgen Biopharmaceuticals Co Property, Plant and Equipment?

Suzhou Zelgen Biopharmaceuticals Co SHSE:688266 +1.69% 70 Property, Plant and Equipment is ¥523 Mil as of Jun. 2026. GuruFocus rates SHSE:688266 with a GF Score™ of 70/100 and a GF Value™ of ¥221.15 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Suzhou Zelgen Biopharmaceuticals Co's quarterly net PPE increased from Dec. 2025 (¥486 Mil) to Mar. 2026 (¥495 Mil) and increased from Mar. 2026 (¥495 Mil) to Jun. 2026 (¥523 Mil).

Suzhou Zelgen Biopharmaceuticals Co's annual net PPE increased from Dec. 2023 (¥271 Mil) to Dec. 2024 (¥363 Mil) and increased from Dec. 2024 (¥363 Mil) to Dec. 2025 (¥486 Mil).


Suzhou Zelgen Biopharmaceuticals Co  (SHSE:688266) Property, Plant and Equipment Explanation

A company with durable competitive advantage doesn't need to constantly upgrade its equipment to stay competitive. The company replaces when it wears out. On the other hand, a company without any advantages must replace to keep pace.

Difference between a company with a moat and one without is that the company with the competitive advantage finances new equipment through internal cash flows, whereas the no advantage company requires debt to finance.

Producing a consistent product that doesn't change equates to consistent profits. There is no need to upgrade plants which frees up cash for other ventures. Think Coca Cola, Johnson & Johnson etc.


Suzhou Zelgen Biopharmaceuticals Co Property, Plant and Equipment Related Terms


Suzhou Zelgen Biopharmaceuticals Co Property, Plant and Equipment Historical Data

* Premium members only.

The historical data trend for Suzhou Zelgen Biopharmaceuticals Co's Property, Plant and Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzhou Zelgen Biopharmaceuticals Co Property, Plant and Equipment Chart

Suzhou Zelgen Biopharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Property, Plant and Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 188.91 247.09 271.21 363.43 485.89

Suzhou Zelgen Biopharmaceuticals Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Property, Plant and Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 366.13 456.80 485.89 495.20 522.62
SHSE:688266
70GF Score
Suzhou Zelgen Biopharmaceuticals Co Ltd SHSE:688266
Property, Plant and Equipment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Suzhou Zelgen Biopharmaceuticals Co Property, Plant and Equipment Calculation

Property, Plant and Equipment (PPE) are the fixed assets of the companyFixed assets are also known as non-current assets.

Property, plant, and equipment includes assets that will - in the normal course of business - neither be used up in the next year nor will become a part of any product sold to customers.

Some of the most common parts of property, plant, and equipment are:


Land
Buildings (and leasehold improvements)
Transportation equipment
Manufacturing equipment
Office equipment
Office furniture

Companies with lots of property, plant, and equipment often have special categories. For example, railroad property includes:


Track
Ties
Ballast
Bridges
Tunnels
Signals
Locomotives
Freight Cars

There is often a note in the financial statements - found in a company's 10-K - that will explain the different categories of property a company owns.

The market value of property, plant, and equipment can differ tremendously from the book value of property, plant, and equipment.

For example, when Berkshire Hathaway liquidated its textile mills, it had to pay the buyers of the company's manufacturing equipment to haul the equipment away. That property, plant, and equipment was literally worth less than zero. On the other hand, some companies own thousands of acres of land.

All property, plant, and equipment other than land is depreciated. Land is never depreciated. However, land is not marked up to market value either. Under Generally Accepted Accounting Principles (GAAP), land is shown on the balance sheet at cost.

The property, plant, and equipment line shown on the balance sheet is usually net property, plant, and equipment. This means it is the cost of the property, plant, and equipment less accumulated depreciation.

What does a Property, Plant and Equipment of ¥523 Mil mean?
Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) has a Property, Plant and Equipment of ¥523 Mil as of Jun. 2026. The total property, plant and equipment recorded on a company's balance sheet less accumulated depreciation. View historical data on Suzhou Zelgen Biopharmaceuticals Co and its competitors.
Is Suzhou Zelgen Biopharmaceuticals Co's Property, Plant and Equipment too high?
Suzhou Zelgen Biopharmaceuticals Co's current Property, Plant and Equipment is ¥523 Mil. Overall, Suzhou Zelgen Biopharmaceuticals Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Suzhou Zelgen Biopharmaceuticals Co's Property, Plant and Equipment compare to VRTX and REGN?
Suzhou Zelgen Biopharmaceuticals Co's Property, Plant and Equipment of ¥523 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Property, Plant and Equipment for a Biotechnology company?
A good Property, Plant and Equipment depends on the Biotechnology industry context. However, Property, Plant and Equipment should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Property, Plant and Equipment mean?
A high Property, Plant and Equipment can signal that a stock is expensive relative to its fundamentals. The total property, plant and equipment recorded on a company's balance sheet less accumulated depreciation. View historical data on Suzhou Zelgen Biopharmaceuticals Co and its competitors. Suzhou Zelgen Biopharmaceuticals Co's current Property, Plant and Equipment is ¥523 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Zelgen Biopharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥221.15, compared to a current price of ¥112.22 — trading 49.3% below its estimated fair value. The current Property, Plant and Equipment is ¥523 Mil. Suzhou Zelgen Biopharmaceuticals Co's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Property, Plant and Equipment calculated?
Property, Plant and Equipment is calculated from a company's financial statements. For Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266), the current Property, Plant and Equipment is ¥523 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) Overvalued in 2026?

Based on GuruFocus' analysis, Suzhou Zelgen Biopharmaceuticals Co stock appears to be undervalued. The current stock price of ¥112.22 is trading 49.3% below its estimated GF Value™ of ¥221.15. GuruFocus considers Suzhou Zelgen Biopharmaceuticals Co to be Significantly Undervalued.

Key valuation signals for SHSE:688266:

  • Property, Plant and Equipment: ¥523 Mil
  • GF Value™: ¥221.15 vs. price of ¥112.22 (49.3% below fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688266 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Suzhou Zelgen Biopharmaceuticals Co Business Description

Address No.209 Chenfeng Road, Yushan Town, Jiangsu Province, Kunshan, CHN
Suzhou Zelgen Biopharmaceuticals Co Ltd is engaged in research and development of new chemical and biological drugs for various therapeutic areas, including tumors, bleeding and blood diseases, and hepatobiliary diseases.
70GF Score

Get the complete analysis for SHSE:688266

Property, Plant and Equipment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥112.22
Price
¥221.15
GF Value